Companies: 10,795·Total market cap: $144.5T
CME Group Inc.

CME Group Inc.

CMENASDAQFinancial Services● Active
$257.40
+$1.34(+0.52%)
Market Cap$93.3B
P/E Ratio
52W High$329.16
52W Low$244.56

CME Group Inc. (CME) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

cme · stock forecast · 35 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 35 Wall Street analysts in the past 3 months

SellBuy

Hold

35 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
13
Hold
17
Sell
5
Strong Sell
0
Total: 35 · Buy rate: 37.1%

12-Month Price Target

High

$353

Consensus

$320

+24.4% upside

Low

$302

Median: $313 · Last Close: $257.40

The CME Group Inc. (CME) analyst consensus is Hold, based on ratings from 35 Wall Street analysts over the past 3 months. The average 12-month CME price target is $320.25, representing +24.4% upside from the current price of $257.40.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $320 (24.4%)

Consensus Target

$320.25

24.4% upside

High Target

$353

37.1%

Low Target

$302

17.3%

Current Price

$257.40

as of today

Based on analyst price targets, the CME stock price prediction for the next 12 months ranges from $302 to $353. The consensus CME price forecast of $320.25 implies 24.4% upside from the current price of $257.40.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$244.535.00%

1-day model range: $243.68–$245.38. Peak: $245.38 (-5.00%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$348+35.4%
2028$429+66.5%
2029$493+91.4%
2030$541+110.0%
2031+123.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

14%0%86%
2Buy
0Neutral
12Sell
RSI (14)21.1Oversold
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · CME · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$254.88BUY
MA 10$267.82SELL
MA 20$280.42SELL
MA 50$288.02SELL
MA 100$294.61SELL
MA 200$282.18SELL
Current $CME · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$258.71SELL
EMA 10$265.89SELL
EMA 20$274.76SELL
EMA 50$284.95SELL
EMA 100$287.70SELL
EMA 200$282.94SELL
Current $CME · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
Morgan Stanley2026-04-23
Maintains
OverweightOverweight
Barclays2026-04-23
Maintains
Equal WeightEqual Weight
Piper Sandler2026-04-15
Maintains
OverweightOverweight
Barclays2026-04-13
Maintains
Equal WeightEqual Weight
Morgan Stanley2026-04-10
Maintains
OverweightOverweight
Barclays2026-04-08
Maintains
Equal WeightEqual Weight
Argus Research2026-03-04
Downgrade ↓
BuyHold
Barclays2026-02-05
Maintains
Equal WeightEqual Weight
RBC Capital2026-02-05
Maintains
Sector PerformSector Perform
Morgan Stanley2026-02-05
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on CME Group Inc. (CME) stock. Of the recent 360 rating actions, 32 were upgrades and 37 were downgrades. 35 analysts currently cover CME.

Analyst Recommendation Trends

Buy ratings13↑ +2
Hold ratings03↑ +3
Sell ratings00

CME analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$7.0B

↓ 10.0% YoY

Revenue Next Year

$7.4B

↑ 4.7% YoY

EPS This Year

$12.26

EPS Next Year

$12.88

↑ 5.0% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast CME EPS of $12.26 for the current fiscal year, based on estimates from 9 analysts. The CME revenue forecast is $7.0B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The CME stock forecast is supported by two independent data sources: analyst consensus ratings from 35 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CME price target is $320.25 (+24.4% upside), with an analyst consensus of Hold.

The CME short-term stock prediction for tomorrow is $244.53 (-5.00%). The CME stock price prediction for 2027 estimates an average of $348. The CME stock prediction for 2030 projects a range of $520–$561.

CME Group Inc. trades on NASDAQ under the ticker CME. The CME stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 37% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

CME forecast · 8 questions

According to 35 Wall Street analysts, the average 12-month CME price target is $320.25, with a high forecast of $353.00 and a low of $302.00. The median price target is shown in the chart above when available. This implies +24.4% potential upside from the current price of $257.40.

CME price targetWhat is CME price targetCME analyst price targetCME 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.